RYR2 and catecholaminergic polymorphic ventricular tachycardia: In agreement with the clinical observations, we showed that treating CPVT hiPSC-CMs with metoprolol does not prevent these abnormalities while flecainide or stabilizing the RyR2 closed state with a Rycal compound do.